Development of a Cell-Based Assay Method for Screening Autoantibodies to Nmda-Receptors in the First Episodes of Schizophrenia and Other Mental Disorders

Abstract

For the early detection and successful treatment of NMDA receptor encephalitis, an easy-to-use and reliable test system must be developed. In addition, it is important to isolate NMDA-receptor encephalitis from various symptomatically similar mental illnesses. A reliable criterion is the detection of antibodies to NMDA receptors in the blood serum and CSF of patients.